The presence of antibodies indicates previous exposure to the SARS-CoV-2 virus but may not always translate into protection against the disease, say scientists, citing imponderables such as what......
The Russia-developed Sputnik V vaccine against coronavirus has been found to be over 95 percent effective, CEO of the Russian Direct Investment Fund (RDIF) Kirill Dmitriev said on Tuesday. ......
The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been......
Scientists have developed a new low-cost nasal swab test which can accurately diagnose the presence of SARS-CoV-2 virus that causes COVID-19 in just 20 minutes. The findings, published in......
Russia's Sputnik V vaccine against COVID-19 has shown 91.6 per cent efficacy in the phase 3 trial without any serious side effects, according to an interim analysis of data published in The Lancet......